Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Human Papillomaviruses in Head and Neck Cancer

  • Markus Hoffmann
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_7151-4


HPV-associated squamous cell carcinomas of the head and neck are a subgroup of tumors that can be defined as a specific tumor entity. Socioepidemiological, biomolecular, and biological data describe significant differences in HPV-infected and noninfected patients giving rise to this opinion.



Head and neck squamous cell carcinoma (HNSCC) arises in the oral cavity, oropharynx, larynx, or hypopharynx and is the sixth leading cancer incidence worldwide representing an estimated 5 % of all cancers. It is likely that approximately 570,000 cases will arise each year worldwide and that only 40–50 % of patients will survive for 5 years. Besides tobacco and alcohol consumption, the etiological involvement of human papillomaviruses (HPV), specifically HPV genotype 16, in the carcinogenesis of HNSCC has proven to be of significant importance in both initiation and progression of these tumors. Starting from first reports showing that HPV plays a role not only...


Tonsillar Carcinoma Cell Cycle Life p16INK4A Overexpression Specific Tumor Entity Anatomical Tumor Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, and Bosch FX (1998) Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58:5–13Google Scholar
  2. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRefPubMedPubMedCentralGoogle Scholar
  3. Hoffmann M, Tribius S, Quabius ES, Henry H, Pfannenschmidt S, Burkhardt C, Görögh T, Halec G, Hoffmann AS, Kahn T, Röcken C, Haag J, Waterboer T, Schmitt M (2012) HPV DNA, E6(*)I-mRNA expression and p16(INK4A) immunohistochemistry in head and neck cancer – how valid is p16(INK4A) as surrogate marker? Cancer Lett 323(1):88–96CrossRefPubMedGoogle Scholar
  4. Quabius ES, Haag J, Kühnel A, Henry H, Hoffmann AS, Görögh T, Hedderich J, Evert M, Beule AG, Maune S, Knecht R, Óvári A, Durisin M, Hoppe F, Tribius S, Röcken C, Ambrosch P, Hoffmann M (2015) Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany, Int J Oncol 414–22Google Scholar
  5. Wiest T, Schwarz E, Enders C, Flechtenmacher C, and Bosch FX (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21:1510–1517CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Hals-, Nasen- und Ohrenheilkunde, Kopf- und HalschirurgieUniversitätsklinikum Schleswig-Holstein, Campus KielKielGermany